Partnerships Partnering News

12.18.2017

CMAC Medicines Manufacturing Consortium Welcomes Pfizer as Newest Partner

11.21.2017

Ground-breaking €34 million project to develop better test for liver disease

11.15.2017

COMBACTE Adds a New Project to its Consortium: COMBACTE-CDI

11.15.2017

UC San Diego Center for Microbiome Innovation Announces Pfizer as Corporate Member

11.01.2017

Encycle Therapeutics announces discovery collaboration with Pfizer Inc.

09.21.2017

LabCentral to Open Next-Stage Facility for Growing Life Science Companies, Supported by Pfizer

07.25.2017

CONSORTIUM ESTABLISHED TO SUPPORT ICH M7 COMPLIANCE

07.25.2017

Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations

07.10.2017

Spark Therapeutics Presents Updated Interim Hemophilia B Data Supporting Consistent and Sustained Response at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress

06.29.2017

Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone’s proprietary PulsarTM Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders

06.07.2017

Sangamo Therapeutics And Pfizer Announce That Sb-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency

06.04.2017

Spark Therapeutics Presents Updated Preliminary Data From Hemophilia B Phase 1/2 Trial Suggesting Consistent And Sustained Levels Of Factor IX Activity At The Hemostasis And Thrombosis Research Society (HTRS) 2017 Scientific Symposium